Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research. Embla’s data acquisition modules, wireless transmission capabilities and proprietary software enable clinicians and researchers to collect, visualize and interpret patient data with accuracy and efficiency.
Serving a global customer base of sleep laboratories, hospital departments and academic research institutions, Embla Medical maintains a network of distributors and service partners across Europe, North America and Asia. The company continues to focus on expanding its footprint in specialized diagnostic markets through ongoing product enhancements and strategic collaborations.
AI Generated. May Contain Errors.
